CD56+CD3- NK cells
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CD56+CD3- NK cells, covering 2015-06-08 to 2015-06-08. Get the full timeline:
Most recent: Clinical Trial Update: CD56+CD3- NK Cells Following Allogeneic Stem Cell Transplantation [Phase 1]